A total of six TFs (AEBP1, TCF21, PRRX2, PRDM6, BNC2, and MEOX2) that increased in HF within the training and test cohorts (Figures S14 and S15) were regarded as key TFs that were activated in HF progression. The gene discussed is MEOX2; the disease is hydrops fetalis.